Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Diluted earnings per share

Latest
1.54
↑ 259% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
-0.97
Historical baseline
PeriodValueYoY Change
TTM1.54+12723.0%
2025-0.01+99.8%
2024-5.00-160.4%
2023-1.92-15.0%
2022-1.67-22.8%
2021-1.36-61.9%
2020-0.84-221.7%
20190.69+206.2%
2018-0.65-38.3%
2017-0.47-